ID
14653
Description
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00841113
Link
https://clinicaltrials.gov/show/NCT00841113
Keywords
Versions (1)
- 4/25/16 4/25/16 -
Uploaded on
April 25, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00841113
Eligibility Prostate Cancer NCT00841113
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Hormone therapy and chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0279025
- UMLS CUI [2]
- C0392920
Description
Cancer complication
Data type
boolean
Alias
- UMLS CUI [1]
- C0596237
Description
Further malignancy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0006826
- UMLS CUI [1,2]
- C0332196
- UMLS CUI [1,3]
- C0007114
Description
Allergies
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C1518041
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C1268855
Description
Coagulation disorder
Data type
boolean
Alias
- UMLS CUI [1]
- C0005779
Description
Pagets disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0029401
Description
QTcB
Data type
boolean
Alias
- UMLS CUI [1]
- C1882512
Similar models
Eligibility Prostate Cancer NCT00841113
- StudyEvent: Eligibility
C0332155 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C1518041 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1268855 (UMLS CUI [2,2])